BioPharma Boardroom
2026 Editorial Calendar

Theme: Shaping Resilient, Responsible, and Revolutionary Biopharma Leadership

Frequency: Monthly • Coverage: Global Biopharma • Regions: North America • Europe • Asia • Middle East • Africa

Filter by region:
JANUARY 2026

Resilience Redefined

Cover Focus: The BioPharma Resilience Index 2026 – Navigating Disruption with Strategy

North America • Europe • Asia • Middle East • Africa
Features
  • Exclusive Q&A: Cytiva, Lonza, and Merck on the new dimensions of manufacturing resilience
  • Top 10 Strategic Shifts in global biopharma for 2026
  • Commentary: R&D budgets under inflationary pressures
  • Leadership Viewpoint: The new era of “co-opetition” in supply chains
  • Regional Focus: Resilience investments and supply-chain localisation across North America, Europe, Asia, Middle East, and Africa.

Supplement: Resilience Playbook 2026

FEBRUARY 2026

Precision in Policy

Cover Focus: Evolving Global Regulatory Landscape – EU MDR, US FDA, CDSCO, NMPA Convergences

North America • Europe • Asia • Middle East • Africa
Features
  • India’s “One Health” regulatory mission
  • Biologics under scrutiny: Harmonisation vs. fragmentation
  • In conversation with regulators – balancing innovation and oversight
  • Market Access Insight: Pricing pressure meets patient value
  • Regional Focus: Key policy shifts and cross-border regulatory harmonisation trends spanning the U.S., EU, China, India, GCC, and South Africa.
MARCH 2026

Cell & Gene Therapy Frontiers

Cover Focus: Scaling the Next-Gen Therapies – Manufacturing, Data, and Delivery

North America • Europe • Asia • Middle East
Features
  • Supply chain maturity models for CGT
  • AI orchestration in personalised therapies
  • Interview: Bluebird Bio and Takeda discuss commercial CGT readiness
  • Spotlight: India’s academic-industry collaborations in cell therapy
  • Regional Focus: CGT commercial readiness and clinical trial ecosystems across the U.S., Europe, Japan, South Korea, and emerging GCC markets.
APRIL 2026

AI in Biopharma

Cover Focus: From Algorithms to Approvals – How AI is Transforming Drug Discovery & Trials

North America • Europe • Asia
Features
  • Generative AI’s leap from molecule design to clinical success
  • Ethical frameworks for AI-powered clinical trials
  • Case Study: AstraZeneca’s AI-R&D transformation roadmap
  • Roundtable: CIOs on digital twins and smart manufacturing
  • Regional Focus: AI-driven biopharma transformation across North America, Europe’s ethical leadership, and Asia’s acceleration hubs.
MAY 2026

Sustainability in Science

Cover Focus: Green Pharma – ESG Strategies that Deliver Real Impact

Europe • Asia • North America
Features
  • Carbon-neutral labs and energy-efficient biomanufacturing
  • Water stewardship and waste minimisation
  • Leadership Panel: ESG commitments vs. shareholder pressure
  • Innovation Insight: Sustainable packaging in pharma supply chains
  • Regional Focus: ESG frameworks and sustainability benchmarks from EU Green Deal policies to Asia’s renewable-energy bioparks.
JUNE 2026

Partnerships & M&A Intelligence

Cover Focus: The Year of Strategic Consolidation – Pharma’s New Power Plays

North America • Europe • Asia • Middle East
Features
  • DealWatch 2026: Key M&A and licensing trends
  • Interview: CFO perspectives on capital efficiency
  • Collaborations in rare disease pipelines
  • Analysis: Outsourcing to CDMOs – balancing agility and control
  • Regional Focus: M&A capital flows across U.S. biotech, European alliances, Asian CDMOs, and sovereign fund activity in the Middle East.
JULY 2026

Workforce & Leadership Transformation

Cover Focus: The Talent Equation – Building the Biopharma Workforce of Tomorrow

North America • Europe • Asia
Features
  • Leadership succession in R&D-driven enterprises
  • Workforce 5.0: Human-machine collaboration in labs
  • Executive Q&A: Leadership in the age of scientific acceleration
  • Gender and inclusion analytics in boardrooms
  • Regional Focus: Leadership transformation and talent pipelines across North American biotech, European R&D, and Asia’s digital workforce.
AUGUST 2026

Market Access & Pricing Reform

Cover Focus: Affordability, Access, and Equity – Rethinking the Global Pricing Playbook

North America • Europe • Asia • Africa
Features
  • Pricing innovation in emerging markets
  • Health economics in rare diseases
  • Case Study: Value-based pricing pilots in Asia
  • Policy Watch: WHO & IFPMA dialogue on equitable access
  • Regional Focus: Reimbursement reforms and affordability models from U.S. IRA updates to Europe’s joint procurement and Africa’s access programmes.
SEPTEMBER 2026

Manufacturing Excellence

Cover Focus: The Smart Biomanufacturing Revolution – Continuous, Connected, Compliant

North America • Europe • Asia • Middle East
Features
  • Next-gen bioprocess automation and PAT tools
  • Data integrity, MES integration, and cyber resilience
  • Panel: CDMO leaders on digital acceleration
  • Special Report: India’s biomanufacturing corridors (Hyderabad, Pune, Bengaluru)
  • Regional Focus: Smart manufacturing hubs emerging across U.S., EU, India, Singapore, and the Middle East.
OCTOBER 2026

The Global Health Economy

Cover Focus: Pandemic Preparedness, Vaccines, and Biodefence – What’s Next?

North America • Europe • Asia • Africa
Features
  • Vaccine manufacturing hubs: post-COVID strategic shifts
  • AMR, diagnostics, and preparedness policy
  • Leadership Roundtable: Global Health CEOs on resilience
  • Market Lens: Public-private partnership success stories
  • Regional Focus: Vaccine resilience and public-health investment across North America, Europe, Africa, and Southeast Asia.
NOVEMBER 2026

The Investor’s View

Cover Focus: Venture, Private Equity, and Sovereign Funds in Biopharma

North America • Europe • Middle East • Asia
Features
  • Top 25 biopharma investments of 2026
  • Interview: Temasek, GIC, and Novo Holdings on biotech bets
  • IPO climate outlook for 2027
  • Insight: Where innovation meets valuation
  • Regional Focus: Investment hotspots and sovereign wealth participation across U.S., EU, Middle East, and Asia.
DECEMBER 2026

The Year in Review

Cover Focus: The BioPharma Leadership Index – Who Moved the Industry in 2026

North America • Europe • Asia • Middle East • Africa
Features
  • CEO Scorecard: Visionaries and disruptors of the year
  • Top 10 breakthroughs and deals
  • Editorial Review: Lessons for 2027
  • Special Feature: Future of biopharma boardrooms – governance, ethics, and AI
  • Regional Focus: Cross-regional performance review – leadership, innovation, and resilience benchmarks across five continents.

Quarterly Specials (Downloadable Reports)

Regular Columns

Partnerships & Collaborations

To sponsor specific months, commission custom research, or integrate campaigns, write to editor@biopharmaboardroom.com.

Enquire Now